SKVI
SKINVISIBLE INCstockOTC
skinvisible, inc., through its wholly owned subsidiary, skinvisible pharmaceuticals, inc., is an r&d pharmaceutical company that develops enhanced, patented dermatology and healthcare products to treat skin conditions from acne to warts, along with sunscreens, anti-aging products, hand sanitizing lotions, pre-surgical preparations, and medical treatments outside of dermatology using its patented technology invisicare®. skinvisible's primary objective is to license these prescription and over-the-counter products into the global dermatology and medical markets. potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products or life cycle management for their existing products. www.invisicare.com and www.skinvisible.com
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.18 | 2026-11-10 | -16.67% | 0.000 |
| 1M | 0.20 | 2026-10-21 | -26.11% | 2.018 |
| 3M | 0.18 | 2026-08-18 | -16.67% | 0.969 |
| 6M | 0.17 | 2026-05-19 | -12.33% | -0.502 |
| 1Y | 0.35 | 2025-11-17 | -57.14% | -0.745 |
| 2Y | 0.62 | 2024-11-27 | -75.61% | — |
| 5Y | 0.29 | 2021-11-22 | -48.28% | -1.312 |
SKINVISIBLE INC (OTC:SKVI) stock price today is $0.15, and today's volume is 3,962. SKVI is down 16.667% today. The 30 day average volume is 2,367. SKVI market cap is $733,476 with 4.89M shares outstanding.